PortfoliosLab logoPortfoliosLab logo
ABT vs. HTO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ABT vs. HTO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Abbott Laboratories (ABT) and H2O America (HTO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ABT achieves a -28.82% return, which is significantly lower than HTO's 18.36% return. Over the past 10 years, ABT has outperformed HTO with an annualized return of 10.94%, while HTO has yielded a comparatively lower 6.53% annualized return.


ABT

1D
-1.64%
1M
4.39%
YTD
-28.82%
6M
-28.92%
1Y
-33.65%
3Y*
-2.76%
5Y*
-2.50%
10Y*
10.94%

HTO

1D
0.74%
1M
3.29%
YTD
18.36%
6M
18.21%
1Y
11.35%
3Y*
-4.86%
5Y*
-0.18%
10Y*
6.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ABT vs. HTO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ABT
Abbott Laboratories
-28.82%12.87%4.81%2.26%-20.68%30.53%28.04%22.08%29.06%52.03%
HTO
H2O America
18.36%2.92%-22.57%-17.78%13.40%7.66%-0.43%30.19%-11.20%16.22%

Correlation

The correlation between ABT and HTO is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Apr 6, 1983

0.17

The correlation between ABT and HTO shifts across timeframes, from 0.13 (1 year) to 0.29 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ABT:

$154.05B

HTO:

$2.20B

EPS

ABT:

$3.59

HTO:

$2.90

PE Ratio

ABT:

24.57

HTO:

19.70

PEG Ratio

ABT:

1.53

HTO:

2.04

PS Ratio

ABT:

3.42

HTO:

2.54

PB Ratio

ABT:

2.33

HTO:

1.20

Total Revenue (TTM)

ABT:

$45.13B

HTO:

$816.28M

Gross Profit (TTM)

ABT:

$25.45B

HTO:

$335.79M

EBITDA (TTM)

ABT:

$10.80B

HTO:

$273.35M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ABT vs. HTO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABT
ABT Risk / Return Rank: 33
Overall Rank
ABT Sharpe Ratio Rank: 11
Sharpe Ratio Rank
ABT Sortino Ratio Rank: 33
Sortino Ratio Rank
ABT Omega Ratio Rank: 33
Omega Ratio Rank
ABT Calmar Ratio Rank: 88
Calmar Ratio Rank
ABT Martin Ratio Rank: 11
Martin Ratio Rank

HTO
HTO Risk / Return Rank: 5454
Overall Rank
HTO Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
HTO Sortino Ratio Rank: 5050
Sortino Ratio Rank
HTO Omega Ratio Rank: 4949
Omega Ratio Rank
HTO Calmar Ratio Rank: 5757
Calmar Ratio Rank
HTO Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABT vs. HTO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and H2O America (HTO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ABTHTODifference
Sharpe ratioReturn per unit of total volatility

-1.84

Sortino ratioReturn per unit of downside risk

-2.70

Omega ratioGain probability vs. loss probability

0.75

1.09

-0.35

Calmar ratioReturn relative to maximum drawdown

-0.88

0.64

-1.52

Martin ratioReturn relative to average drawdown

-1.92

1.48

-3.40

ABT vs. HTO - Sharpe Ratio Comparison

The current ABT Sharpe Ratio is -1.40, which is lower than the HTO Sharpe Ratio of 0.45. The chart below compares the historical Sharpe Ratios of ABT and HTO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ABT vs. HTO - Drawdown Comparison

The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum HTO drawdown of -54.53%. Use the drawdown chart below to compare losses from any high point for ABT and HTO.


Loading charts...

Drawdown Indicators


ABTHTODifference

Max Drawdown

Largest peak-to-trough decline

-45.66%

-54.53%

+8.87%

Max Drawdown (1Y)

Largest decline over 1 year

-38.99%

-16.19%

-22.80%

Max Drawdown (3Y)

Largest decline over 3 years

-39.64%

-35.14%

-4.50%

Max Drawdown (5Y)

Largest decline over 5 years

-39.64%

-42.85%

+3.21%

Max Drawdown (10Y)

Largest decline over 10 years

-39.64%

-42.85%

+3.21%

Current Drawdown

Current decline from peak

-35.53%

-24.64%

-10.89%

Average Drawdown

Average peak-to-trough decline

-10.84%

-15.90%

+5.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.75%

6.98%

+10.77%

Volatility

ABT vs. HTO - Volatility Comparison

Abbott Laboratories (ABT) has a higher volatility of 7.71% compared to H2O America (HTO) at 6.85%. This indicates that ABT's price experiences larger fluctuations and is considered to be riskier than HTO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ABTHTODifference

Volatility (1M)

Calculated over the trailing 1-month period

7.71%

6.85%

+0.86%

Volatility (6M)

Calculated over the trailing 6-month period

19.48%

16.54%

+2.94%

Volatility (1Y)

Calculated over the trailing 1-year period

24.51%

23.12%

+1.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.06%

24.06%

-2.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.67%

29.56%

-5.89%

Dividends

ABT vs. HTO - Dividend Comparison

ABT's dividend yield for the trailing twelve months is around 2.77%, less than HTO's 3.01% yield.


PositionTTM20252024202320222021202020192018201720162015
ABT
Abbott Laboratories
2.77%1.88%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%
HTO
H2O America
3.01%3.43%3.25%2.33%1.77%1.86%1.85%1.69%2.01%1.63%1.45%2.63%

Financials

ABT vs. HTO - Financials Comparison

This section allows you to compare key financial metrics between Abbott Laboratories and H2O America. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20222023202420252026
11.16B
183.29M
(ABT) Total Revenue
(HTO) Total Revenue
Values in USD except per share items

ABT vs. HTO - Profitability Comparison

The chart below illustrates the profitability comparison between Abbott Laboratories and H2O America over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%60.0%20222023202420252026
56.3%
0
Portfolio components
ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.

HTO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, H2O America reported a gross profit of 0.00 and revenue of 183.29M. Therefore, the gross margin over that period was 0.0%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.

HTO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, H2O America reported an operating income of 37.43M and revenue of 183.29M, resulting in an operating margin of 20.4%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.

HTO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, H2O America reported a net income of 19.01M and revenue of 183.29M, resulting in a net margin of 10.4%.


Frequently Asked Questions


ABT and HTO have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABT has higher volatility (7.71%) compared to HTO (6.85%). In terms of maximum drawdown, ABT dropped -45.66% vs HTO's -54.53%.

HTO currently has the higher Sharpe Ratio (0.45 vs -1.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ABT and HTO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer